Ganser A - Search Results

1

Interleukin-3 and granulocyte-macrophage colony-stimulating factor in combination: clinical implication.

Frisch J, Ganser A, Hoelzer D, Brugger W, Kanz L, Mertelsmann R, Schulz G. Frisch J, et al. Among authors: ganser a. Med Pediatr Oncol Suppl. 1992;2:34-7. doi: 10.1002/mpo.2950200709. Med Pediatr Oncol Suppl. 1992. PMID: 1306886 Clinical Trial.

2

Sequential in vivo treatment with two recombinant human hematopoietic growth factors (interleukin-3 and granulocyte-macrophage colony-stimulating factor) as a new therapeutic modality to stimulate hematopoiesis: results of a phase I study.

Ganser A, Lindemann A, Ottmann OG, Seipelt G, Hess U, Geissler G, Kanz L, Frisch J, Schulz G, Herrmann F, et al. Ganser A, et al. Blood. 1992 May 15;79(10):2583-91. Blood. 1992. PMID: 1586711 Free article. Clinical Trial.

3

In vivo effects of granulocyte-macrophage colony-stimulating factor and interleukin-3 on clonal and non-clonal cell populations in patients with clonal hematopoietic disorders.

Ganser A, Janssen JW, Ottmann OG, Seipelt G, Eder M, Becher R, Lindermann A, Herrmann F, Schulz G, Mertelsmann R, et al. Ganser A, et al. Leukemia. 1991 Jun;5(6):487-92. Leukemia. 1991. PMID: 1676079

4

The effect of recombinant human granulocyte-macrophage colony-stimulating factor on neutropenia and related morbidity in chronic severe neutropenia.

Ganser A, Ottmann OG, Erdmann H, Schulz G, Hoelzer D. Ganser A, et al. Ann Intern Med. 1989 Dec 1;111(11):887-92. doi: 10.7326/0003-4819-111-11-887. Ann Intern Med. 1989. PMID: 2683920

5

Treatment of myelodysplastic syndromes with hematopoietic growth factors.

Ganser A, Hoelzer D. Ganser A, et al. Hematol Oncol Clin North Am. 1992 Jun;6(3):633-53. Hematol Oncol Clin North Am. 1992. PMID: 1377194 Review.

6

Myelokathexis treated with recombinant human granulocyte-macrophage colony-stimulating factor (rhGM-CSF).

Hess U, Ganser A, Schnürch HG, Seipelt G, Ottmann OG, Falk S, Schulz G, Hoelzer D. Hess U, et al. Among authors: ganser a. Br J Haematol. 1992 Feb;80(2):254-6. doi: 10.1111/j.1365-2141.1992.tb08910.x. Br J Haematol. 1992. PMID: 1550786 No abstract available.

7

Clinical use of recombinant human hematopoietic growth factors (GM-CSF, IL-3, EPO) in patients with myelodysplastic syndrome.

Herrmann F, Mertelsmann R, Lindemann A, Ottmann OG, Seipelt G, Oster W, Hoelzer D, Ganser A. Herrmann F, et al. Among authors: ganser a. Biotechnol Ther. 1991;2(3-4):299-311. Biotechnol Ther. 1991. PMID: 1845132 Clinical Trial.

8

Recombinant human interleukin-3 in patients with hematopoietic failure.

Ganser A, Lindemann A, Seipelt G, Ottmann OG, Eder M, Herrmann F, Frisch J, Schulz G, Mertelsmann R, Hoelzer D. Ganser A, et al. Recent Results Cancer Res. 1991;121:162-72. doi: 10.1007/978-3-642-84138-5_18. Recent Results Cancer Res. 1991. PMID: 1857856 Clinical Trial.

9

Biologic effects of recombinant human interleukin-3 in vivo.

Lindemann A, Ganser A, Herrmann F, Frisch J, Seipelt G, Schulz G, Hoelzer D, Mertelsmann R. Lindemann A, et al. Among authors: ganser a. J Clin Oncol. 1991 Dec;9(12):2120-7. doi: 10.1200/JCO.1991.9.12.2120. J Clin Oncol. 1991. PMID: 1960553 Clinical Trial.

10

Expression of the c-fes proto-oncogene in granulocyte-macrophage colony-stimulating factor-dependent acute myelogenous leukemia cells grown autonomously.

Brach MA, Gauer E, Ludwig WD, Ganser A, Mertelsmann R, Herrmann F. Brach MA, et al. Among authors: ganser a. Int J Cell Cloning. 1991 Jan;9(1):89-94. doi: 10.1002/stem.5530090111. Int J Cell Cloning. 1991. PMID: 2010659 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

888 results

Search Page

Filters